About this trial
Gestational diabetes (GDM) is a type of diabetes that occurs as a result of intolerance of carbohydrate metabolism during pregnancy in an individual whose blood glucose concentration is within normal limits before pregnancy. GDM is an important condition that should be handled carefully. Because it is one of the most common metabolic diseases during pregnancy and poses risks to the health of the mother, fetus and newborn. Increasing Self-Efficacy in Gestational Diabetes with education based on the Health Belief Model,
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Between the ages of 18-35,
In the second trimester,
Primiparous,
Have adequate communication skills,
Disqualifiers
Pregnant women with risky pregnancies,
Multiple pregnancies were not included in the study.
Pregnant women with previous type 1 or type 2 diabetes,
Have a psychiatric diagnosis,
Trial design
Parallel
Treatments tested in this trial
Education group
BehavioralThe training materials were prepared in line with the researchers and expert opinions were obtained. Trainings will be given for two weeks. After the trainings are completed, reminder information will be sent to the pregnant women via text messages every other day to inform them that the trainings are continuing. Reminder information prepared as text messages will be sent to the pregnant women's mobile phones. 4 weeks after the first training, the same training will be reminded again via WhatsApp as a summary training by emphasizing key points. The trainings will be carried out by an expert researcher in the field. In the training content prepared in line with WhatsApp, the risks that may be seen during pregnancy and Gestational Diabetes Mellitus; * Sensitivity perception and Seriousness perception, perceived risks that may be seen during pregnancy * Health motivation perception, the pregnant woman's beliefs and practices regarding being healthy, * Benefit perception, pregnancy follow
Treatment groups
Trial outcomes
Primary outcomes
Pregnancy Risk Perception Scale (GRP)
The scale was developed by Heaman and Gupton (2009) to assess the risk perception of pregnant women. The Turkish validity and reliability study of the scale was conducted by Evcili and Dağlar (2019) . The risk perception scale consists of 9 items and 2 sub-dimensions. The scale is a visual analog measurement tool. The scale consists of 9 items and 2 factors. There is a 0-100 mm linear line immediately below each item in the scale, indicating "no risk" and "extremely high risk". The total score of the scale is found by adding the scores for each of the nine items and dividing the obtained score by 9. A score can also be made for the factors of the scale: The score for the "Risk perception of the pregnant woman towards her baby" factor is found by adding the scores for each of the 5 items under this factor and dividing the obtained score by 5. The score for the "Risk perception of the pregnant woman towards herself" factor is obtained by add
Self-Efficacy Scale in Gestational Diabetes (GESGD):
Developed by Polat and Avdal (2020), the Self-Efficacy Scale in Gestational Diabetes is a five-point Likert-type scale consisting of 23 items and four sub-dimensions. The total Cronbach alpha value of the scale was determined as 0.654. Its sub-dimensions are Diet and Weight Management, Complication Precautions, Nutrition Education Compliance and Medical Treatment Applications. It has been emphasized that as the score to be obtained from the scale increases as a result of the coding of the positive and negative expressions in the scale, the individual's self-efficacy will increase and that he/she will be able to effectively perform his/her own care as a result of the training he/she receives.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: